Please ensure Javascript is enabled for purposes of website accessibility

Boston Scientific Begins Selling Low-Cost Ventilator Alternative

By Eric Volkman – Apr 19, 2020 at 5:36PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's Coventor will retail for under $1,000.

Addressing an urgent need arising from the SARS-CoV-2 coronavirus outbreak and the COVID-19 disease that can result from it, Boston Scientific (BSX -0.89%) is manufacturing a new, relatively inexpensive "ventilator alternative." This product, which is to be branded under the name Coventor, received Food and Drug Administration (FDA) Emergency Use Authorization approval last Thursday.

The device can serve as a backup ventilator for patients with significant respiratory difficulties, in situations where a standard ventilator is unavailable or impractical. It is much smaller, and its construction is simpler, than standard ventilators. Roughly the size of a cereal box, it utilizes a mechanical arm that compresses a ventilation bag to deliver air into a patient.

Coronavirus.

Image source: Getty Images.

Boston Scientific told MedTech Dive that it will manufacture 3,000 Coventors initially, with the possibility of scaling this number higher in the likely case that demand proves strong. The company will sell Coventor at cost, with a price point under $1,000. By comparison, standard ventilators can cost in excess of $20,000 apiece. 

A great many countries, such as the U.S., lack enough standard ventilators in their healthcare systems to cope with the sharp increase of advanced-stage COVID-19 patients. Such individuals frequently suffer from severe respiratory problems.

The Coventor technology was developed by researchers and an alumnus at the University of Minnesota. The university said the device's specifications will be made open-source, which will allow other manufacturers to produce it.

"Our hope is that the Coventor will be useful in those clinical settings where traditional ventilators are not available," the University quoted Stephen Richardson, one of the device's designers, as saying.

On Friday, Boston Scientific stock rose by just over 8%, well ahead of the gains of the broader equities market.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Boston Scientific Corporation Stock Quote
Boston Scientific Corporation
BSX
$38.02 (-0.89%) $0.34

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
327%
 
S&P 500 Returns
105%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.